. Design and sequences of the GalNAc-siRNA conjugates used in this study.
• Supplementary Table 2. Primer and template sequences used in the mitochondrial polymerase incorporation and inhibition assays.
• Supplementary Table 3. Primer and template sequences used in the mitochondrial polymerase chain termination assays.
• Supplementary Table 4. Cell culture conditions. Quantification of 2′-F-monomers in rat liver 24 hours after 81 doses of revusiran (STC).
(B) Quantification of 2′-F-monomers in rat heart 24 hours after 81 doses of revusiran (STC). • Supplementary Figure 5 . Intracellular uptake of 2′-F-monomers in cell-based assays. 2′-F-nucleosides were incubated with HepG2, SkMC, Caki-1, COLO 205, cells at 10 µM (2′-F-A, 2′-F-G, and 2′-F-C) or 250 µM (2′-F-U) for 24 hours.
• Supplementary Figure 6 . Effects of 2′-F-monomers on mitochondrial DNA in cells. 2′-Fnucleosides, ddC, and sofosbuvir (SOF) were added to cells grown in galactosecontaining media on days 0, 3, 7, and 10. DNA was extracted on day 11. Mitochondrial MT-CO1 DNA and nuclear SDHA DNA were quantified using qPCR. 
S and AS represent sense and antisense strands; upper-case and lower-case letters indicate 2'-deoxy-2'-fluoro (2′-F) and 2'-O-methyl (2′-OMe) ribosugar modifications, respectively; • indicate PS linkage; L indicates the trivalent GalNAc ligand (structure above).
Supplementary Table 2 . Primer and template sequences used in the mitochondrial polymerase incorporation and inhibition assays.
POLRMT Pol γ
Primer 
The 5′-fluorophore was Atto-425. 
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